ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOWA COMPANY, LTD.
  3. Financials
  4. Accounts payable

KOWA COMPANY, LTD. (E02819)

Market cap
P/E ratio
Kowa develops and sells prescription and over-the-counter medicines including popular nutritional drinks and cold remedies, while also operating trading, optical equipment, and hospitality businesses across 117 global subsidiaries.
SummaryFinancialsDividendsHistoryWorkforce
Period EndAccounts payable (Million JPY)YoY (%)
Mar 31, 202395,962+26.47%
Mar 31, 202275,875+1.75%
Mar 31, 202174,569-3.90%
Mar 31, 202077,595-3.39%
Mar 31, 201980,315-14.69%
Mar 31, 201894,150+21.89%
Mar 31, 201777,241+4.88%
Mar 31, 201673,647+0.40%
Mar 31, 201573,355+27.67%
Mar 31, 201457,457+35.59%
Mar 31, 201342,374

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat